Enzo Biochem Inc. (ENZ) experienced unusually high volume on Jun. 12, as the stock lost 0.66% to a closing price of $3.00. The stock saw 464,780 shares trade hands over the course of the day on 1,896 trades.
Shares of Enzo Biochem, Inc. (NYSE:ENZ) rose by 1.35% in the past week and 20% for the last 4 weeks. In the past week, the counter has outperformed the S&P 500 by 1.29% and the outperformance increases to 21.64% for the last 4 weeks.
Enzo Biochem Inc. (ENZ) experienced unusually high volume on Jun. 10, as the stock lost 1.61% to a closing price of $3.05. The stock saw 631,062 shares trade hands over the course of the day on 3,095 trades.
Enzo The '824, '767, '928, and '830 patents, which are owned by Plaintiffs-Appellants Enzo Biochem, Inc., Enzo Life Sciences, Inc., and Yale University ("Enzo"), are directed to various techniques for labeling and detecting nucleic acids. More ...